AAP
AMPE

Arax Advisory Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Arax Advisory Partners’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$10 – 2587
2024
Q1 		$10 Hold
10
– – ﹤0.01% 1308
2023
Q4 		$21 Hold
10
– – ﹤0.01% 1325
2023
Q3 		$37 Sell
10
-9
-47% -$39 ﹤0.01% 1310
2023
Q2 		$89 Hold
19
– – ﹤0.01% 1254
2023
Q1 		$89 Hold
19
– – ﹤0.01% 1253
2022
Q4 		$85 Sell
19
-309
-94% -$1.99K ﹤0.01% 1253
2022
Q3 		$6K Sell
328
-1,769
-84% -$62K ﹤0.01% 775
2022
Q2 		$106K Hold
2,097
– – 0.02% 308
2022
Q1 		$296K Hold
2,097
– – 0.04% 184
2021
Q4 		$359K Hold
2,097
– – 0.05% 164
2021
Q3 		$1.04M Hold
2,097
– – 0.14% 69
2021
Q2 		$1.05M Buy
+2,097
New +$1.13M 0.14% 68
2020
Q4 		$979K Hold
2,052
– – 0.14% 60
2020
Q3 		$589K Hold
2,052
– – 0.1% 77
2020
Q2 		$392K Sell
2,052
-3,842
-65% -$639K 0.07% 91
2020
Q1 		$734K Buy
+5,894
New +$1.07M 0.17% 62

Other funds holding AMPE

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SWM
Sanctuary Wealth Management Pocatello, Idaho $151M AUM 17.94% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

Arax Advisory Partners's AMPE Position: Q2 2024 in Review

Arax Advisory Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2024, closing a stake of 10 shares — an estimated $10 sold.

Arax Advisory Partners first reported a position in AMPE in Q1 2020 and held it in 16 quarters. The position peaked at $1.05M in Q2 2021. 6 funds tracked by Wall St. Rank hold AMPE as of Q2 2024.

  • Arax Advisory Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2024 after selling out during the quarter.
  • Arax Advisory Partners sold 10 Ampio Pharmaceuticals Inc. shares in Q2 2024, an estimated $10.
  • Arax Advisory Partners first reported a position in Ampio Pharmaceuticals Inc. in Q1 2020 and held it in 16 quarters.
  • Arax Advisory Partners's Ampio Pharmaceuticals Inc. position peaked at $1.05M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2024.

Based on Arax Advisory Partners's 13F filing for Q2 2024, filed 6 Aug 2024.